Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Side effects after artificial hair implants: 2 case reports

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations
Original languageEnglish
JournalLeukemia and Lymphoma
Pages (from-to)1-4
Number of pages4
ISSN1042-8194
DOIs
Publication statusPublished - 1 Jul 2019

ID: 57730900